Board approves Managing Director succession, CFO change and director renewal

Cfo ResignedManagement Changes View source PDF Explain this filing

ASIANTNE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+13.3%Reaction day

₹9.70

prior close

₹10.60

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+13.0% vs market

Trading & Distributors peers, median of 132sector+0.0%+13.3% vs sector

On the reaction day the stock moved 13.0 pts more than Nifty Microcap 250 and 13.3 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.3

10m

+3.6

15m

+1.0

30m

+3.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+13.3+0.3+13.0+0.0+13.3

Next day

+7.0+0.6+6.4-0.1+7.1

+4.3-0.4+4.7-1.4+5.7

+0.5-0.9+1.5-1.6+2.1

+0.6-0.3+1.0-1.3+1.9

+0.4+0.3+0.1-0.8+1.2

-3.3+1.3-4.6-1.5-1.8

15d

-5.2-0.1-5.0-2.6-2.5

-5.2-1.2-3.9-3.0-2.2

-9.9-7.7-2.2-8.4-1.5

—————

UpDownMarket · Nifty Microcap 250Sector · Trading & Distributors peers, median of 132Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

On 28 August 2026: Hariram Garg will step down as Managing Director on 28 September for health reasons but remain Chairman and non-executive director, subject to shareholder approval. Sunil Garg, his son, will become Managing Director for five years through 27 September 2031, subject to shareholder approval. Rajesh Garg resigns as finance chief on 7 September; Raunak Garg replaces him. Akhil Manglik was renewed for five years from 6 September 2026.

Likely market impact

Planned successors may limit disruption, though the health-related Managing Director exit and family succession may keep governance in focus.